On March 19, 2017, 43 athletes gathered in New York City for the United Airlines NYC Half Marathon. The team raised over $85,000 for NF research!
The Children’s Tumor Foundation NF Endurance Team gives participants the opportunity to run, bike, or swim in endurance events across the country. We asked one of our athletes, Dawn Lowell, why she races with us and what it means to her family.
This month marks the eighth consecutive Cupid’s Undie Run to benefit the Children’s Tumor Foundation. Cupid’s has grown in leaps and bounds since 2010, when participants raised $10,000 to now, in 2017, when they’ve brought their eight year total to over $10 million for NF research. Everyone’s favorite Valentine’s-themed party has shown us all once again what an amazing group of people can do for the NF cause.
Triathletes will compete and raise money to fund rare disease research
NEW YORK -- The Children’s Tumor Foundation (CTF) is pleased to be the exclusive official charity partner for the Tri Fort Worth triathlon, which takes place in Fort Worth, Texas on May 21, 2017. The Children’s Tumor Foundation is the leading nonprofit organization dedicated to funding research for neurofibromatosis (NF), a genetic disorder that causes tumors to grow on nerves throughout the body. NF affects one in 3,000 people of all populations; currently there is no effective treatment or cure.
On May 17, hundreds of landmarks in the U.S., U.K., Canada, and Australia will “Shine a Light on NF” to raise awareness for rare genetic disorder
NEW YORK – February 1, 2017 – The Children’s Tumor Foundation is pleased to announce that in May, in honor of NF Awareness Month, buildings, bridges, monuments, and landmarks across the globe will show their support in the fight against neurofibromatosis (NF) by lighting up in blue and green, the official colors of NF. NF is a genetic disorder that affects 1 in 3,000 births of all populations, and causes tumors to grow on nerves throughout the body. It can lead to blindness, deafness, bone abnormalities, disfigurement, learning disabilities, disabling pain, and cancer. There is not yet a cure.